Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile | table of contents
GTC Biotherapeutics Inc - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 01/01/2008
- Report Title: GTC Biotherapeutics Inc - Premium Company Profile
- View Report Summary: View Report Summary
- Report Type: Company Profile
- Country: Global
- Number of Pages: 48
TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 9
Company Financials 11
Stock Market Performance 11
P&L 12
Balance Sheet 15
Cash Flow 15
Business Segment Performance 16
Products & Services 17
Pipeline Products 17
AC Forecast Product Sales 20
Competitors and Strategic Business Relationships 21
Key Competitors 21
Key Suppliers 22
Key Clients 22
Shareholding Structure 23
Strategy 24
Company View 24
Corporate Strategy 29
SWOT Analysis 30
Overview 30
Strengths 31
Weaknesses 32
Opportunities 33
Threats 34
Value Chain Analysis 35
Overview 35
Discovery and Product Development 35
Manufacturing 36
Scorecard 37
Overview 37
Scorecard Analysis 38
Key Employees 39
List of Key Employees 39
Key Employee Biographies 40
Financial and Operational Overview 45
Financial and Operational Overview 45
APPENDIX 48
Ask the analyst 48
Datamonitor consulting 48
Disclaimer 48
TABLE OF FIGURES
Figure 1: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
TABLE OF TABLES
Table 1: GTC Biotherapeutics - Key Facts 6
Table 2: GTC Biotherapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
Table 3: GTC Biotherapeutics - Key Events Impacting Share Price Performance 11
Table 4: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
Table 5: GTC Biotherapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 14
Table 6: GTC Biotherapeutics - Balance Sheet, 2002-2006 ($ Mn) 15
Table 7: GTC Biotherapeutics - Cash Flow, 2002-2006 ($ Mn) 15
Table 8: GTC Biotherapeutics - Revenue Breakdown, 2002-2006 ($ Mn) 16
Table 9: GTC Biotherapeutics – In-house Pipeline Products 17
Table 10: GTC Biotherapeutics - Collaboration Pipeline 18
Table 11: GTC Biotherapeutics- Key Strategic Revenues, 2006-2010 ($ Mn) 20
Table 12: GTC Biotherapeutics - Key Competitors 22
Table 13: GTC Biotherapeutics - Key Suppliers 22
Table 14: GTC Biotherapeutics - Key Clients 22
Table 15: GTC Biotherapeutics - Key Shareholders 23
Table 16: GTC Biotherapeutics - SWOT Analysis Summary 30
Table 17: GTC Biotherapeutics – Value Chain Analysis 35
Table 18: GTC Biotherapeutics – Scorecard 37
Table 19: GTC Biotherapeutics - Key Employees 39
Table 20: GTC Biotherapeutics - Financial and Operational Overview 46
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 9
Company Financials 11
Stock Market Performance 11
P&L 12
Balance Sheet 15
Cash Flow 15
Business Segment Performance 16
Products & Services 17
Pipeline Products 17
AC Forecast Product Sales 20
Competitors and Strategic Business Relationships 21
Key Competitors 21
Key Suppliers 22
Key Clients 22
Shareholding Structure 23
Strategy 24
Company View 24
Corporate Strategy 29
SWOT Analysis 30
Overview 30
Strengths 31
Weaknesses 32
Opportunities 33
Threats 34
Value Chain Analysis 35
Overview 35
Discovery and Product Development 35
Manufacturing 36
Scorecard 37
Overview 37
Scorecard Analysis 38
Key Employees 39
List of Key Employees 39
Key Employee Biographies 40
Financial and Operational Overview 45
Financial and Operational Overview 45
APPENDIX 48
Ask the analyst 48
Datamonitor consulting 48
Disclaimer 48
TABLE OF FIGURES
Figure 1: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
TABLE OF TABLES
Table 1: GTC Biotherapeutics - Key Facts 6
Table 2: GTC Biotherapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
Table 3: GTC Biotherapeutics - Key Events Impacting Share Price Performance 11
Table 4: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
Table 5: GTC Biotherapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 14
Table 6: GTC Biotherapeutics - Balance Sheet, 2002-2006 ($ Mn) 15
Table 7: GTC Biotherapeutics - Cash Flow, 2002-2006 ($ Mn) 15
Table 8: GTC Biotherapeutics - Revenue Breakdown, 2002-2006 ($ Mn) 16
Table 9: GTC Biotherapeutics – In-house Pipeline Products 17
Table 10: GTC Biotherapeutics - Collaboration Pipeline 18
Table 11: GTC Biotherapeutics- Key Strategic Revenues, 2006-2010 ($ Mn) 20
Table 12: GTC Biotherapeutics - Key Competitors 22
Table 13: GTC Biotherapeutics - Key Suppliers 22
Table 14: GTC Biotherapeutics - Key Clients 22
Table 15: GTC Biotherapeutics - Key Shareholders 23
Table 16: GTC Biotherapeutics - SWOT Analysis Summary 30
Table 17: GTC Biotherapeutics – Value Chain Analysis 35
Table 18: GTC Biotherapeutics – Scorecard 37
Table 19: GTC Biotherapeutics - Key Employees 39
Table 20: GTC Biotherapeutics - Financial and Operational Overview 46
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
